Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Trieste
Clinical trial register · Italy

Clinical Trials in Trieste, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Burlo Garofolo9 Novartis Pharmaceuticals6 International Piezosurgery Academy6 Ospedali Riuniti Trieste4 Hoffmann-La Roche3
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Trieste

96 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Kardigan, Inc.
Phase 3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-08-26
Recruiting
Novartis Pharmaceuticals
Phase 2
60
Florence, Roma, Trieste, Vicenza
2026-06-26
Recruiting
AventaMed DAC
Observational
160
Trieste
2026-05-21
Recruiting
Casa di Cura Dott. Pederzoli
Observational
200
Bologna, Padova, Roma, Trieste, Udine, Peschiera del Garda
2026-04
Recruiting
Zanubritnib and Anti-MAG Neuropathy
NCT07392229Anti-MAG IgM-associated Demyelinating Polyneuropathy
DrugZanubrutinib
Azienda Ospedaliera di Padova
Phase 2
50
Milan, Padova, Pavia, Roma, Trieste
2026-03-24
Recruiting
Kardigan, Inc.
Phase 2/3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-02-13
Recruiting
Generate Biomedicines
Phase 3
786
Trieste, Brescia
2026-01-20
Recruiting
University Hospital, Grenoble
Observational
1,600
Bari, Catanzaro, Rovigo, Sanremo, Torino, Trento, Trieste, Venice
2026-01-15
Recruiting
Novo Nordisk A/S
Phase 3
460
Milan, Novara, Verona, Trieste
2026-01-08
Recruiting
Ascendis Pharma A/S
Phase 3
186
Florence, Genova, Naples, Trieste
2025-12-12
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Roma, Torino, Trieste
2025-10-09
Recruiting
Transcranial Alternating Current Stimulation in Lewy Body Dementia
NCT07375771Lewy Body Dementia (LBD), Transcranial Alternating Current Stimulation
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
40
Brescia, Trieste
2025-10-01
By invitation
International Piezosurgery Academy
Not applicable
60
Trieste
2025-10-01
Recruiting
Alfasigma S.p.A.
Phase 3
80
Alessandria, Ancona, Milan, Naples, Rome, Trieste
2025-09-29
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Bologna, Ravenna, Trieste, Brescia, Ascoli Piceno, Perugia
2025-09-26
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Gussago, Trieste, Bologna, Genova, Milan, Pavia
2025-09-16
Not yet open
GUIDO CAMANNI
Observational
150
Padova, Assisi, Roma, Salerno, Trieste, Varese, Naples
2025-09-15
Recruiting
Azienda Sanitaria Universitaria Integrata del Trentino
Not applicable
52
Trieste, Sterzing, Trento
2025-09-10
Active, closed
Literacy Skills Improvement and Early Diagnosis of Specific Learning Disorders (SLD) Using a New Phono Syllabic Program
NCT07510126Acquisition of Literacy Skills for All Children, Including Those With SLDs, Appropriateness of Referrals for SLD Assessment for Accurate Early Detection of SLDs
IRCCS Burlo Garofolo
Not applicable
1,407
Trieste
2025-09-05
Recruiting
Basilea Pharmaceutica
Phase 3
234
Genova, Milan, Modena, Pavia, Pisa, Trieste
2025-08-26
Recruiting
Sanofi
Phase 3
90
Florence, Genoa, Milan, Naples, Meldola, Novara, Palermo, Trieste
2025-08-18
Recruiting
Kedrion S.p.A.
Phase 3
40
Florence, Novara, Trieste, Torino, Vicenza
2025-08-13
By invitation
Rede Optimus Hospitalar SA
Not applicable
620
Palermo, Pisa, Catania, Mestre, Roma, Siena, Trieste
2025-08-08
Recruiting
Eli Lilly and Company
Phase 1/2
68
Bologna, Milan, Roma, Trieste
2025-07-30
Active, closed
Boehringer Ingelheim
Phase 1
16
Brescia, Trieste
2025-07-29
Recruiting
AbbVie
Phase 3
120
San Giovanni Rotondo, Naples, Rome, Trieste
2025-07-28
Recruiting
University of Trieste
Not applicable
40
Trieste
2025-07-20
Active, closed
Calluna Pharma AS
Phase 2
150
Padova, Roma, Siena, Trieste, Modena, Naples, Rozzano
2025-06-20
Recruiting
Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT07013370Immunoglobulin Prophylaxis, Cytomegalovirus Infections, Allogeneic Hematopoietic Stem Cell Transplantation, Transplant-Related Disorder
Antonello Di Paolo, M.D., Ph.D.
Observational
150
Trieste
2025-06-02
By invitation
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)
Observational
2,500
Trieste
2025-06-01
Recruiting
At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis
NCT07006571ALS, ALS (Amyotrophic Lateral Sclerosis)
University of Trieste
Not applicable
40
Trieste
2025-05-19
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Active, closed
IRCCS Burlo Garofolo
Not applicable
228
Trieste
2025-04-23
Not yet open
Evaluating Decision-making Using ChatGPT-4 Among Trainees in Surgery
NCT06921447Artificial Intelligence (AI), Training, Surgery
Ospedali Riuniti Trieste
Observational
35
Trieste
2025-04-10
Recruiting
Effect Of Cavitation In Post-Extractive Socket Healing
NCT06866431Cavitation, Healing of Extraction Socket
International Piezosurgery Academy
Observational
84
Trieste
2025-04-01
Not yet open
IRCCS Burlo Garofolo
Observational
100
Reggio Emilia, Trieste, Udine
2025-04-01
Recruiting
BeOne Medicines
Phase 3
300
Bologna, Lecce, Meldola, Trieste, Verona
2025-03-05
Recruiting
International Piezosurgery Academy
Observational
32
Trieste
2025-01-31
Active, closed
International Piezosurgery Academy
Observational
150
Trieste
2025-01-01
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
NCT06836011ATTR Amyloidosis With Cardiomyopathy, ATTR-CM, ATTR Amyloidosis Wild Type, Mitral Regurgitation
Medical University of Vienna
Observational
600
Brescia, Ferrara, Trieste
2025-01-01
Not yet open
Ospedali Riuniti Trieste
Not applicable
60
Trieste
2025-01
Not yet open
Ospedali Riuniti Trieste
Observational
950
Trieste
2025-01
Recruiting
Basilea Pharmaceutica
Phase 3
450
Cuneo, Genoa, Milan, Modena, Pavia, Pisa, Siena, Trieste
2024-12-11
Active, closed
International Piezosurgery Academy
Observational
30
Trieste
2024-12-01
Recruiting
Takeda
Phase 3
30
Genova, Messina, Naples, Rome, Trieste
2024-11-19
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Bergamo, Bologna, Roma, San Giovanni Rotondo, Trieste
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Foggia, Monza, Palermo, Pavia, Roma, Sassari, Ivrea, Trieste
2024-10-24
Recruiting
argenx
Phase 3
69
Bassano del Grappa, Florence, Milan, Novara, Ravenna, Reggio Emilia, Torino, Trieste
2024-10-18
Active, closed
Novo Nordisk A/S
Phase 4
500
Florence, Milan, Roma, Trieste, Verona
2024-09-17
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Florence, Genova, Milan, Padova, Roma, Trieste
2024-05-28
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
1,000
Aviano, Caserta, Naples, Trieste
2024-05-13
Recruiting
Umbria Bioengineering Technologies
Not applicable
10,000
Genova, Foligno, Trieste
2024-03-15
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bergamo, Bologna, Florence, Pescara, Roma, San Giovanni Rotondo, Trieste
2024-01-19
Recruiting
Azienda Ospedaliero-Universitaria di Modena
Not applicable
30
Roma, Trieste, Modena, Naples
2024-01-17
Active, closed
International Piezosurgery Academy
Observational
60
Trieste
2024-01-06
Recruiting
Comparison of NOM for ACLD Between Medical and Surgical Ward
NCT06265649Diverticulitis, Colon Disease, Acute Diverticulitis
Ospedali Riuniti Trieste
Observational
175
Trieste
2024-01-01
Recruiting
Intellia Therapeutics
Phase 3
1,200
Bologna, Cona, Florence, Genova, Pavia, Pisa, Trieste
2023-12-13
Recruiting
Biologic Characterization of Patients With ITP
NCT05694325Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
200
Bologna, Piacenza, Roma, Torino, Trieste
2023-11-27
Recruiting
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT06158698Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure
DrugColchicine
Niguarda Hospital
Phase 3
80
Naples, Bologna, Trieste, Udine, Rome, Milan, Turin, Ancona
2023-11-14
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ancona, Modena, Florence, Milan, Pisa, Roma, Trieste, Bergamo
2023-10-25
Recruiting
IRCCS Burlo Garofolo
Observational
54
Trieste
2023-09-13
Recruiting
IRCCS Burlo Garofolo
Observational
22
Trieste
2023-07-21
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bari, Foggia, Naples, Modena, Trieste, Pavia, Ranica
2023-07-06
Recruiting
Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
NCT05698277Congenital Heart Defect, Cardiac Function
Anna Erenbourg
Observational
495
L’Aquila, Milan, Trieste
2023-05-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Trieste, Monza, Palermo
2023-03-16
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Bologna, Florence, Roma, Trieste, Vicenza
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Bologna, Roma, Trieste
2023-02-02
Recruiting
Istituto Oncologico Veneto IRCCS
Observational
150
Brixen, Abano Terme, Dolo, Bassano del Grappa, Mestre, Padova, Trieste, Udine
2023-01-23
Recruiting
Umbria Bioengineering Technologies
Not applicable
600
Genova, Foligno, Trieste
2023-01-07
Recruiting
Shionogi
Phase 1/2
24
Milan, Torino, Trieste
2023-01-04
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Florence, Naples, Roma, Torino, Trieste, Verona
2022-12-15
Recruiting
Istituto Auxologico Italiano
Observational
3,000
Mascalucia, Bari, Milan, Reggio Emilia, Trieste
2022-10-01
Recruiting
IRCCS Burlo Garofolo
Observational
250
Monza, Roma, Torino, Trieste
2022-07-30
Recruiting
IRCCS Burlo Garofolo
Observational
20
Florence, Milan, Trieste
2022-06-13
Active, closed
Direzione centrale salute, politiche sociali e disabilità
Observational
450
Aviano, Trieste
2022-06-10
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Florence, Genova, Milan, Monza, Padova, Roma, Trieste
2022-05-19
Recruiting
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
NCT05198570Herpesviridae Infections, Herpes Simplex 1, Varicella Zoster Virus Infection, Transplantation Infection
University of Pisa
Observational
200
Trieste
2021-09-15
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Recruiting
IRCCS Burlo Garofolo
Observational
81
Trieste
2021-07-21
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bergamo, Brescia, Florence, Genova, Milan, Palermo, Torino, Trieste
2021-07-13
Active, closed
University Hospital of Ferrara
Not applicable
249
Ferrara, Bologna, Forlì, Palermo, Ravenna, Rimini, Trieste
2021-06-03
By invitation
Cytokinetics
Phase 2/3
900
Florence, Milan, Naples, Pisa, Roma, Trieste
2021-05-06
Recruiting
Guerbet
Phase 4
2,076
Siena, Trieste, Milan, Roma, Verona
2021-03-24
Active, closed
EMN Trial Office S.r.l. Impresa Sociale
Phase 2
50
Bari, Milan, Perugia, Roma, Trieste, Udine
2021-03-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Bari, Tricase, Milan, Bologna, Trieste
2020-08-20
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aviano, Bari, Calabria, Monza, Naples, Roma, Segrate, Trieste
2020-08-19
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Recruiting
IRCCS Burlo Garofolo
Not applicable
67
Trieste
2019-06-17
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Active, closed
Philogen S.p.A.
Phase 3
214
Genova, Milan, Padova, Naples, Siena, Trieste, Turin
2016-07-01
Rows per page Showing 1–96 of 96
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/trieste

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 96 of those studies with a site in Trieste.

How many clinical trials are recruiting in Trieste?

63 of the 96 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 24 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Trieste), 96 studies
PhaseStudiesRecruitingShare
Phase 3352436.5%
Observational312132.3%
Not applicable15915.6%
Phase 2636.3%
Phase 1/2333.1%
Phase 2/3323.1%
Phase 4212.1%
Phase 1101%

Most active sponsors

Lead sponsors with the most studies (Trieste)
Lead sponsorStudiesRecruiting
IRCCS Burlo Garofolo96
International Piezosurgery Academy62
Novartis Pharmaceuticals63
Ospedali Riuniti Trieste41
Eli Lilly and Company32
Hoffmann-La Roche31
Janssen Research & Development, LLC31
argenx22
Basilea Pharmaceutica22
Kardigan, Inc.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.